Clinical Trials on Breast Cancer Patients in United States

Total 25863 results

H. Lee Moffitt Cancer Center and Research Institute

Completed

Evaluation of Patient Functionality and Utility of Web-Based Personal Health History and Risk Assess

Cancer | Cancer Screening Patients | Patient Volunteers

United States
EarlySense Ltd.

Withdrawn

Evaluation of EverOn™ System in Medical / Surgical Ward

Post Operative Patient | Patients Requiring PCA | Respiratory Patients | Patients in Risk of Fall

United States
University of Arizona

Completed

Estradiol Levels in Patients Treated With Estring

Estrogen Levels Among Breast Cancer Patients

United States
Merrimack Pharmaceuticals
Sanofi

Completed

A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer

ER Positive, Her2 Negative Breast Cancer Patients | Triple Negative Breast Cancer Patients

United States
Johns Hopkins University

Withdrawn

Home Visits for Patients at Risk for Appointment No-shows (SNAP HOME)

Engagement, Patient | Utilization, Health Care | No-Show Patients

United States
Merrimack Pharmaceuticals

Completed

Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer

Her2 Negative Breast Cancer Patients

United States, Spain, Canada, Germany, Russian Federation
Yorkshire Ambulance Service NHS Trust

Unknown

Referral to Pharmacists - Ambulance Clinician Experience Survey (REPLACES)

Pharmacist-Patient Relations | Fall Patients

United Kingdom
University of Virginia

Recruiting

Breaking Bad News to Family Members in a Pandemic

Resident Education, Patient Communication, Breaking Bad News to Patients Remotely, Telemedicine

United States
Dana-Farber Cancer Institute

Completed

TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)

Breast Cancer | Prostate Cancer | Patient Engagement | Patient Satisfaction | Patient Preference

United States
The Leeds Teaching Hospitals NHS Trust

Recruiting

Comparison of Patient Reported Outcome Measures Using the BREAST-Q Questionnaire in Patients Undergoing Pre Versus Sub-pectoral Implant Based Immediate Breast Reconstruction. (PROM-Q)

Breast Cancer | Surgery | Patient Satisfaction | Breast Disease

United Kingdom
University of Virginia
Northwestern University

Active, not recruiting

Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design

Engagement, Patient | Depression, Anxiety

United States
Yale University
Food and Drug Administration (FDA)

Active, not recruiting

The In4M Study: Integrating 4 Methods to Assess Physical Function in Cancer Patients

Quality of Life | Lymphoma | Cancer, Breast | Physical Function | Patient Empowerment | Patient Education

United States
Canon Medical Systems, USA

Completed

Verification of Imaging System PCD-1000A

Cancer Patients

United States
Milton S. Hershey Medical Center

Completed

Effect of Group Led Creative Writing on Mood in Cancer Patients

Cancer Patients

United States
Northwestern University
National Cancer Institute (NCI)

Not yet recruiting

Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer | Estrogen-receptor-positive Breast Cancer | HER2/Neu-Negative Breast Cancer | Advanced Breast Cancerv

United States
Memorial Sloan Kettering Cancer Center
Columbia University; NYU Langone Health; Roswell Park Cancer Institute; Jacobi... and other collaborators

Recruiting

Food: A Three-Arm Study Examining Food Insecurity Interventions

Cancer Patients

United States
Thomas Jefferson University

Completed

A Chatbot-Powered G8 Screening Intervention to Facilitate Referrals to a Comprehensive Geriatric Assessment Among Older Adults With Cancer

Geriatric Cancer Patients

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

Assessing the Impact of Electronic Capture of Patient Reported Outcomes in Radiation Oncology

Patients With Lung, Breast, Head and Neck, or Pelvic Malignancies

United States
Mayo Clinic

Completed

Histology of Functional Density in Postmenopausal Breast

Breast Cancer | Dense Breasts

United States
Mayo Clinic

Completed

Histology of Functional Density in Premenopausal Breast

Breast Cancer | Dense Breasts

United States
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center

Active, not recruiting

Smoking Cessation Intervention for Cancer Patients

Newly Diagnosed Cancer Patients

United States
St. Jude Children's Research Hospital

Recruiting

Writing Intervention With Adolescents and Young Adults With Cancer

Cancer Patients | Communication Research

United States
Greater Baltimore Medical Center

Withdrawn

Panomics Relationships in the Epidemiology of Cancer Through In Silico Expression (PRECISE)

Cancer | Patients With Clinical and Environmental Risk Factors for Cancer | Patients With a Suspected or Confirmed Diagnosis of Cancer

United States
Memorial Sloan Kettering Cancer Center
Columbia University; University of Michigan; University of Aarhus; University of...

Recruiting

A Study Comparing Two Types of Supportive Interventions for Caregivers of Patients With Cancer

Cancer Patients | Family Caregivers

United States
M.D. Anderson Cancer Center

Completed

Barriers Affecting Physical Activity

Cancer Patients and Physical Activity

United States
Texas A&M University

Unknown

Nutrition Intervention During Chemotherapy

Cancer Patients Receiving Chemotherapy or Chemoradiotherapy

United States
Weill Medical College of Cornell University
Avon Foundation

Completed

The Effect Of Meditation On Quality Of Life In Women With Breast Cancer And Other Gynecological Cancers

Gynecologic Cancer | Breast Cancers

United States
University of Colorado, Denver
Colorado State University

Withdrawn

Virtual Reality in Imaging Review for Cancer Patients

Virtual Reality | Diagnostic Imaging | Patient Education | Cancer Patient

United States
University of Washington

Terminated

Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy

Breast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage IIB | Breast Cancer Stage IIA | Breast Cancer Stage IIIA | Breast Cancer Stage IIIB | Breast Cancer Stage IIIc

United States
University of Washington
National Cancer Institute (NCI)

Completed

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast...

United States
Northwestern University
Eisai Inc.

Unknown

Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients

Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...

United States
University of Washington
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer

HER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer

United States
Elevar Therapeutics
Bukwang Pharmaceutical, Co., Ltd.

Completed

Dose-Escalation and Safety Trial of YN968D1

Cancer Patients With Solid Tumors

Korea, Republic of, United States
Abramson Cancer Center of the University of Pennsylvania

Completed

LIVESTRONG Survivorship Care Plan: Continued Data Collection and Follow Up Survey

Cancer Patient

United States
Baylor Breast Care Center

Recruiting

Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer (RESPONSE)

Breast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer Invasive

United States
Ohio State University Comprehensive Cancer Center

Completed

Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast Cancer

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Stage III Breast Cancer

United States
University of Michigan
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer Therapies

Breast Cancers

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Endoscopic Breast Surgery in Treating Patients With Breast Cancer

Male Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Synta Pharmaceuticals Corp.; New York University...

Completed

Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer

HER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

Inflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast Cancer

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer

HER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer

United States
University of Colorado, Denver

Active, not recruiting

Window of Opportunity Study Targeting the Inflammatory Milieu

Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer

United States
University of California, Irvine
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting

Breast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast Cancer

United States
University of Washington
National Cancer Institute (NCI)

Completed

Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery

HER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-positive Breast Cancer

United States
Joseph Baar, MD, PhD

Completed

MUC1 Vaccine for Triple-negative Breast Cancer

Breast Cancer | Stage I Breast Cancer | Inflammatory Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer

United States
Mayo Clinic
Marker Therapeutics, Inc.

Completed

Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer

HER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer

United States
University of Washington
National Cancer Institute (NCI)

Completed

ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment

Male Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer

United States
Case Comprehensive Cancer Center
National Institute on Minority Health and Health Disparities (NIMHD)

Completed

Attitudes, Beliefs, and Preferences of Older Stage I-III Breast Cancer Survivors Towards Physical Activity

Cancer Survivor | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

High-Intensity Interval Training for Stage I-III Breast Cancer Patients

Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer

United States
National Cancer Institute (NCI)

Terminated

Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer

Male Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer

United States

Clinical Trials on Breast Cancer Patients in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations